Lipid-Altering Efficacy and Safety of Simvastatin 80 mg/Day: Long-Term Experience in a Large Group of Patients with Hypercholesterolemia
- 作者Leiv Ose; Michael H. Davidson; William Insull; Mei Wu; Ann C. Tate; Michael R. Melino; Michele Mercuri; Yale B. Mitchel; Evan A. Stein; Johannes J. P. Kastelein; Russell S. Scott; Donald B. Hunninghake; Santiago Campodonico; Ivan D. Escobar; Michael E. Stepanavage; Helmut G. Schrott
- 卷第23卷
- 期第1期
- 印刷ISSN0160-9289
- 电子ISSN1932-8737
- 文件大小929.81KB
- 发表时间2000
- DOI10.1002/clc.4960230108
- 页码39-46
Endocarditis prophylaxis yes: Endocarditis prophylaxis noC. Richard Conti; C. Richard Conti · 2003
Development of a Cardiovascular Rehabilitation Program: Focus on ExerciseConti, C. Richard; Conti, Jamie B.; Plasschaert, Jeff · Cardiovascular Innovations and Applications · 2018
Use of cardiac resynchronization therapy to optimize beta-blocker therapy in patients with heart failure and prolonged QRS durationJuan M. Aranda Jr; Gregory W. Woo; Jamie B. Conti; Richard S. Schofield; C. Richard Conti; James A. Hill · 2005
Results of medical versus surgical treatment of unstable angina pectorisRichard O. Russell Jr.; C. Richard Conti; Eugene Passamani · 1983
Coronary Artery SpasmC. RICHARD CONTI · 1987
Statin associated symptomsC. Richard Conti · 2007
What coronary stenoses need PCI/stent?C. Richard Conti · 2007
Heparin AnticoagulationC. Richard Conti · 2007